U.S. STOCKS ON THE MOVE-Spotify, Akero Therapeutics, Cyxtera Technologies
U.S. STOCKS ON THE MOVE-Tesla, Moderna, Oil tanker firms
Brief: Portage Biotech Reports Updated Interim Data For Cancer Treatment
Portage Biotech rises on interim data from cancer treatment trial
U.S. STOCKS ON THE MOVE-NeoGames, SandRidge Energy, Shake Shack
Brief: Portage Biotech Announces Results For Fiscal Quarter Ended December 31, 2022
Portage Biotech Inc reports results for the quarter ended in December - Earnings Summary
Portage Biotech Inc expected to post a loss of 23 cents a share - Earnings Preview
Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary
Brief: Portage Biotech Announces Results For Fiscal Quarter Ended September 30, 2022
Portage Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview
Portage Biotech rises on Merck collaboration for cancer therapy
Brief: Portage Biotech Announces Clinical Trial Collaboration Agreement With Merck
Brief: Portage Biotech Provides Research And Development Update
Brief: Portage Biotech Reports Quarterly Loss Per Share Of $0.13
Brief: Portage Biotech Inc - CEO Dr. Ian Walters to take on additional responsibility as chairman of board
Brief: Portage Biotech Acquires Outstanding Minority Interest Of Invariant Natural Killer T Cell (Inkt) Agonist Platform
Brief: Portage Biotech Announces Acquisition Of Four Candidates Targeting The Adenosine Pathway
NASDAQ RESUMED AT 09:48 AM